The company has issued more shares over this period, which dilutes each existing shareholder’s stake.
Diluted shares outstanding: 119.1M (2018) → 121.6M (2022)
Global Cord Blood Corporation (GCBC), alongside its associated entities, provides specialized services related to umbilical cord blood within the People's Republic of China. The company's operations involve the testing, processing, and long-term storage of cord blood for both private subscribers and donated samples. For the latter, it also facilitates donor matching. As of March 31, 2022, GCBC managed three cord blood banks situated in key regions: Beijing municipality, Guangdong province, and Zhejiang province. The company, which is headquartered in Central, Hong Kong, rebranded as Global Cord Blood Corporation in March 2018, having previously been known as China Cord Blood Corporation. Currently, it functions as a subsidiary under Blue Ocean Structure Investment Company Ltd.
When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.
-5.7% YoY
YoY Growth Rate
Revenue declining
-21.4% YoY
YoY Growth Rate
Earnings declining
¥22M/ year
↓ Declining (-6% vs prior year)
1.8% of revenue
R&D spend declining — could signal cost-cutting or efficiency
5+ years
¥1.1B cash & investments at current burn rate
Global Cord Blood Corporation's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.
The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.
Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.
ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Slight earnings drop. Typical near a cyclical low.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Interest coverage above 8. Profits cover interest many times over.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
P/E under 10. The price tag is small relative to last year's profit.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Yield above 6% — often a flag the market is pricing in a cut.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
